GMP Cytokines Market Size, Statistics Report 2022, 2027

report image

GMP Cytokines Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (TNF, Interleukins, Growth Factors, and Others), and Application (Cell and Gene Therapy, Tissue- Engineered Products, and Others), and Geography

Publication Month: Jan 2021 | Report Code: TIPRE00008212 | No. of Pages: 145 | Category: Medical Device | Status: Published

The GMP cytokines market was valued at US$ 84.72 million in 2019 and it is estimated to grow at a CAGR of 8.1% from 2020 to 2027.

GMP cytokines are used in cell and gene therapy for expansion and differentiation of various cell types, ex vivo cultures, and other therapeutic approaches. Moreover, these are used in various tissue engineered products for clinical applications. Additionally, extensive research is being conducted on cytokines to discover new therapeutic approaches to treat chronic conditions. The growth of the GMP cytokines market is mainly attributed to the factors such as increase in acceptance of cytokines cancer and autoimmune therapies, and potential contribution in the stem cell therapy. However, high cost associated with GMP cytokines therapy is projected to deter the market growth.

Lucrative Regions for GMP Cytokines Market



Lucrative Regions for GMP Cytokines Market

Get more information on this report :


Market Insights

Growing Acceptance of Cytokines for Cancer and Autoimmune Therapies

Cytokines play significant role in the regulation of innate and adaptive immunity, which enable cells of the immune system to communicate over short distances. The cytokine therapy to activate the immune system of cancer patients has been an essential parameter in the treatment of cancer and continues to be a prime contributor to present clinical cancer research. Interferon-alpha is one of the approved cytokines for the adjuvant treatment of refractory malignancies. Several research activities have proved the ability of cytokines to limit tumor cell growth by a direct anti-proliferative or pro-apoptotic activity. Moreover, some cytokines inhibit the tumor growth indirectly by stimulating the cytotoxic activity of immune cells against tumor cells. This effectiveness of cytokines therapies over cancer coupled with increasing prevalence of the disease is likely to drive the market by 2027. According to the World Health Organization, in 2019, approximately 9.6 million deaths across the globe were due to cancer.

Additionally, increasing number of investments and collaborations to develop cytokine therapies over cancer and autoimmune diseases are also expected to accelerate the market growth. For instance, in September 2020, Synthekine Inc. raised US$ 82.0 million through rounds of series funding. The company is engaged in the development of cytokine therapeutics for the treatment of cancer and autoimmune disorders.

Type -Based Insights

Based on type, the GMP cytokines market is segmented into TNF, interleukin, growth factor, and others. The growth factors segment held the largest share of the market in 2019; whereas, the TNF segment is anticipated to register the highest CAGR of 8.7% in the market during the forecast period.

GMP Cytokines Market, by Type – 2019 and 2027



GMP Cytokines Market, by Type – 2019 and 2027

Get more information on this report :


Application-Based Insights

Based on application, the GMP cytokines market is segmented into cell and gene therapy, tissue-engineered products, and others. The cell and gene therapy segment held the largest share of the market in 2019; whereas, the tissue engineered products segment is anticipated to register the highest CAGR in the market during the forecast period.

Strategic Insights

Report Coverage - GMP Cytokines Market
Report CoverageDetails
Market Size Value inUS$ 84.72 Million in 2019
Market Size Value byUS$ 158.13 Million by 2027
Growth rateCAGR of 8.1% from 2020-2027
Forecast Period2020-2027
Base Year2020
No. of Pages145
No. of Tables56
No. of Charts & Figures68
Historical data availableYes
Segments coveredType , and Application , and Geography
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Collaboration is one of the major strategies adopted by the GMP cytokines market players to enlarge customer base worldwide, which also permits them to maintain their brand name globally.

GMP Cytokines Market – by Type

  • TNF
  • Interleukins
  • Growth Factors
  • Others

GMP Cytokines Market – by Application

  • Cell and Gene Therapy
  • Tissue Engineered Products
  • Others

GMP Cytokines Market – by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
  • South and Central America

    • Brazil
    • Argentina
    • Rest of South and Central America

Company Profiles

  • Miltenyi Biotec
  • Sino Biological Inc.
  • ABCAM
  • PeproTech Inc.
  • Akron Biotech
  • CellGenix GmbH
  • BIO-TECHNE CORPORATION
  • CREATIVE BIOARRAY
  • Proteintech Group Inc.
  • REPROCELL Inc

Frequently Asked Questions

GMP cytokines are used in cell and gene therapy for expansion and differentiation of various cell types, ex vivo cultures and other therapeutic approaches. Moreover, these are also used in various tissue engineered products for clinical applications. Additionally, extensive research is being conducted on cytokines to discover new therapeutic approaches to treat chronic conditions
The global GMP cytokines market growth is mainly attributed to factors such as increase in acceptance of cytokines cancer and autoimmune therapies and potential contribution in the stem cell therapy. However, high cost associated with GMP cytokines therapy is projected to deter the market growth.
The GMP cytokines market majorly consists of the players such as Miltenyi Biotec, Sino Biological, Inc., ABCAM, PeproTech, Inc., Akron Biotech, CellGenix GmbH, BIO-TECHNE CORPORATION, CREATIVE BIOARRAY, Proteintech Group, Inc., and REPROCELL Inc. among others.

The List of Companies - GMP Cytokines Market

  1. Miltenyi Biotec
  2. Sino Biological Inc.
  3. ABCAM
  4. PeproTech Inc.
  5. Akron Biotech
  6. CellGenix GmbH
  7. BIO-TECHNE CORPORATION
  8. CREATIVE BIOARRAY
  9. Proteintech Group Inc.
  10. REPROCELL Inc
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the GMP cytokines  market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global GMP cytokines  market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00008212
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount